Introduction
Over the last four years, research laboratories and private institutions have produced a relevant number of monoclonal antibodies against Class II histocom patibility antigens, which are membrane protein di mers made of two non-covalently associated chains, alpha and beta.
The large majority of these antibodies are reactive only with the beta chain, or with the a ß dimer [1] ; this has led to the conclusion that the complex, in its native state, is folded with the beta chain on the outside, while the immunogenic epitopes of the alpha chain are normally concealed by the three dimensional folding of the protein molecule, and therefore less accessible [2] , The relative paucity of anti-a Mo Abs can be also explained by the fact that, in most protocols, hybridoma supernatants are screened by indirect binding assays with intact cells as targets. There are however several indications that the majority of anti-a MoAbs does not bind to living cells [3, 4] , Anti-a MoAbs might therefore be missed in conventional screening assays. Only by using sophisticated miniaturized Western Blot screening As an alternative approach for preparing specific reagents for the alpha chain, one might attempt to raise an immune response against synthetic frag ments selected from the glycoprotein primary struc ture: over the last five years it has been widely dem onstrated that a peptide from almost any region of a protein may elicit antibodies capable of recognizing the entire protein, if originally located on the surface of that protein, and that this property is not depend ent on the immunogenicity of the fragment in the complex antigen [5] . This approach might therefore provide an additional set of anti-alpha antibodies to employ for the study of relationships between struc ture and function of the alpha chain.
Following the same approach used for HLA-class II beta chains [6, 7] , we synthesized five peptides corresponding to known amino acid sequences of D Q 1 alpha chain glycoproteins, and tested which of the resulting antipeptide antibody would be reactive with intact cells expressing Class II histocompatibili ty antigens. In addition, we immunized a rabbit with intact cells, and attempted the isolation of anti-Class II antibodies by the use of immunoadsorbents pre pared from Sepharose and three of the five synthetic fragments.
This investigation moreover might provide the lo cation of buried and exposed regions of the native protein, and define which of the surface stretches contains an immunogenic determinant.
Peptides
The five peptides were selected from the primary sequence of DQ1 alpha chain (Table I) 
Antibodies
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Rabbits were immunized with KLH-peptide complexes using the same procedures reported in previous investigations [7] . A sixth rabbit (566) was injected with whole M14 (H LA -D R 4, w6; D Q w l, w3) cells with the same schedule previously de scribed for Namalwa cells [6] .
Methods
Specific antipeptide antibodies were obtained from the sera of all rabbits by chromatography of the IgGs, precipitated by ammonium sulfate at 33% sat uration, on 0 .8 x 4 cm columns packed with affinity adsorbents prepared by linking Sepharose-AH to the synthetic fragments by aid of glutaraldehyde [6] . Antibodies were eluted by 0.2 m glycine-HCl buffer. pH 2.6, dialyzed against PBS, and stored at -20 °C until used.
Binding test
The binding of the antibodies to the antigens was routinely assayed with an ELISA. Wells of microtiter plates were coated with 1 pig of synthetic peptide, or 2 x 104 cells, and dried carefully at 30 °C. Immune sera were diluted 1:100 or 1:500, antibodies to 10 |Ag/ml, and used in the amount of 50 (il. The antigen-antibody complex was then reacted with goat antirabbit-horseradish peroxidase lg (GAR-HRP).
o-Phenylendiamine was used as the substrate. The reaction was stopped after 10 min, by addition of 25 (j,l of 4 n sulforic acid, then the plates were read at 492 nm in a Titertek Multiskan. 
lmmunoprecipitation
Immune sera and affinity-purified antibodies were also tested in immunoprecipitation of highly purified, iodine-labeled Class II glycoproteins, using rabbit preimmune serum or IgG as negative controls. The sera were used in the amount of 1.25 [il, with five serial dilutions, antibodies were adjusted to 100 pig/ml and used in the amount of 5 |il, with three serial dilutions.
Results
After four immunizations with KLH-peptide com plexes, the five rabbit antisera were tested with an ELISA against the five inciting fragments. All sera but anti-M were able to react with the immunogen ( 43 100 
E T A W R W PE F SK F G G F D P Q G A L R N M A V A K H N L N IM IK R Y N ST A A T N E V P E V T F S K S P V T 101 148 L G Q P N T L IC L V D N IFP PV V N IT W L SN G Q SV T E D V SE T S F L S K S D HSF E l D Q 1 (5 4 -6 1 ) FGGFDPQG E 2 D Q 1 ( 4 7 -6 1 ) R WP E F S KFGGFDPQG DR -L E -------GR-AS -E A ------DQ2 K L -L-H R LR ------------------DQ3 Q L -L -R R -R P -----------------
) E D V S E T S F L S K S D D R T G -------------V ------PRE-
pressing different DQ and DR specificites, is that antibodies to E2 appear to be partially specific for DQ 1 alpha chains, while antibodies to H bind all DQ but presumably not DR alpha chains. The binding of both anti-E2 and both anti-H to highly purified, iodine-labeled Class II glycoproteins extracted from cells was relatively low. This might be explained by the fact that DQ molecules, on the cell membrane, are much less represented that DR molecules: apparently, the antibodies were specific enough to bind preferentially, or exclusively, to DQ alpha chains. Sequence homology between positions 47 and 61 of DR and DQ 1 alpha chains is 46%, and 53% between positions 132 and 144 (Table I) ; this low sequence homology between DQ and DR glyco proteins in the stretches considered might result in a low affinity of the two antibodies for DR alpha chains, and explain the low binding to iodine-labeled Class II glycoproteins.
Finally, it should be mentioned that all anti-alpha chain monoclonal antibodies recently described by Cohen [2] were all directed against framework deter minants, and did not show allotype restriction. Since DR molecules are much more represented on the cell membrane, than other Class II glycoproteins, it is likely that most antibodies to DQ alpha chains, in cluding those directed to fragments H and E 2, were missed in the screening assay.
The present investigation suggests that the new technology based on synthetic peptides might not only allow the mapping of surface regions of HLAClass II alpha chains, but also produce a panel of anti-alpha chain reagents comparable to that avail able from hybridoma techniques.
